Email this article Activity of myocardial sympathico-adrenal system in various volume of viable myocardium in chronic cardiac failure
- Authors: Kukes VG1, Sychev DA1, Andreev DA1, Golukhova EZ1, Ostroumov EN1, Dmitrieva IM1
-
Affiliations:
- Issue: Vol 79, No 2 (2004)
- Pages: 49-52
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29765
- ID: 29765
Cite item
Full Text
Abstract
Aim. To estimate sympathetic activity in patients with ischemic heart disease (IHD) complicated by chronic cardiac failure (CCF) depending on the volume of viable myocardium measured by dobutamine stress echocardiography (DSE).
Material and methods. Planar myocardial I-231-MIBG scintigraphy and dobutamine stress echocardiography were made in 16 patients (9 males and 7 females) aged 43-75 years with CCF (NYHA class II- III) and ejection fraction under 35%. The ratio maximal MIBG absorption in the left ventricular myocardium to maximal MIBG absorption in the mediastenum (H/M) and lung (H/L) were estimated. Results. By DSE the patients were divided into two groups: responders in whom contractility improved by 4 and more points (9 patients) and non-responders in whom contractility improved by less than 4 scores (7patients). The groups did not differ by clinical and hemodynamic parameters but group 2 patients had significantly lower H/M and H/L than group 1 patients (1.38 ± 0.02 and 1.08 ± 0.06 against 1.61 ± 0.09 and 1.25 ± 0.12, respectively, p < 0.05). A direct correlation was found between MIBG absorption (H/M, H/L) and ejection fraction on minimal dobutamine doses (r = 0.77, p < 0.01; r = 0.87, p < 0.001), gain in ejection fraction (r = 0.77, p < 0.01; r = 0.45, p < 0.05), and inverse correlation between MIBG absorption (H/M, H/L) and dyssynergia index on minimal dobutamine doses (r = -0.80, p < 0.001; r = -0.87, p < 0.0001).
Conclusion. Patients with CCF demonstrate a correlation between sympathetic activity and volume of viable myocardium, inotropic reserve.
Material and methods. Planar myocardial I-231-MIBG scintigraphy and dobutamine stress echocardiography were made in 16 patients (9 males and 7 females) aged 43-75 years with CCF (NYHA class II- III) and ejection fraction under 35%. The ratio maximal MIBG absorption in the left ventricular myocardium to maximal MIBG absorption in the mediastenum (H/M) and lung (H/L) were estimated. Results. By DSE the patients were divided into two groups: responders in whom contractility improved by 4 and more points (9 patients) and non-responders in whom contractility improved by less than 4 scores (7patients). The groups did not differ by clinical and hemodynamic parameters but group 2 patients had significantly lower H/M and H/L than group 1 patients (1.38 ± 0.02 and 1.08 ± 0.06 against 1.61 ± 0.09 and 1.25 ± 0.12, respectively, p < 0.05). A direct correlation was found between MIBG absorption (H/M, H/L) and ejection fraction on minimal dobutamine doses (r = 0.77, p < 0.01; r = 0.87, p < 0.001), gain in ejection fraction (r = 0.77, p < 0.01; r = 0.45, p < 0.05), and inverse correlation between MIBG absorption (H/M, H/L) and dyssynergia index on minimal dobutamine doses (r = -0.80, p < 0.001; r = -0.87, p < 0.0001).
Conclusion. Patients with CCF demonstrate a correlation between sympathetic activity and volume of viable myocardium, inotropic reserve.
References
- Кушаковский М. С. Хроническая застойная сердечная недостаточность. СПб, 1998.
- Агеев Ф. Т., Мареев В. Ю., Лопатин Ю. М., Беленков Ю. Н. Роль различных клинических, гемодинамических и нейрогуморальных факторов в определении тяжести хронической сердечной недостаточности. Кардиология 1995; 11: 4-12.
- Беленков Ю. Н., Саидова М. А. Оценка жизнеспособности миокарда: клинические аспекты, методы исследования. Там же. 1999; 1:6-13.
- Ferrari R., Ceconi С., Curello S., Visioli O. The neuroendocrine and sympathetic nervous system in congestive heart failure. Eur. Heart J. 1998; 18: 45-51.
- Остроумов E. Н., Андреев Д. А. Радионуклидная диагностика в кардиологии. В кн.: Бокерия Л. А., Голухова Е. 3. (ред.) Лекции по кардиологии. М.; 2001; т. 1: 108-118.
- Сычев Д. А., Кукес В. Г., Андреев Д. А., Остроумов Е. Н. Клиническое значение сцинтиграфии миокарда с метайодобензилгуанидином для оценки фармакодинамической эффективности р-адреноблокаторов, применяемых при хронической сердечной недостаточности. Сердеч. недостаточность 2001; 2: 61-64.
- Senior R., Lahiri A. Role of dobutamine echocardiography in detection of myocardial viability for predicting outcome after revascularization in ischemic cardiomyopathy. J. Am. Soc. Echocardiogr. 2001; 14(3): 240-248.
- Абдулаев P. Я. Клиническая эхокардиография при ишемической болезни сердца. Харьков; 2001.
- Geleijnse M. L., Fioretti P. М., Roelandt J. R. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J. Am. Coll. Cardiol. 1997; 30(3): 595-606.
- Shan K., Bick R. G., Poindexter B. J. et al. Altered adrenergic receptor density in myocardial hibernation in humans. Circulation 2000; 102: 2599-2606.
- Bristow M. R., Hershberger R. E., Port J. D. et al. p-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990; 82: 12-15.
- Colucci W. S., Denniss A. R., Leatherman G. F. et al. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. J. Clin. Invest. L988; 81: 1103-1110.
Supplementary files
